New Leadership at TFRI
Effective August 1st, 2021, Dr. Jim Woodgett, PhD, FRSC, a senior scientist based at the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health will become the new President and Scientific Director of The Terry Fox Research Institute (TFRI).
Dr. Woodgett is an internationally renowned biologist at the LTRI conducting research in cell signalling and transduction pathways in cancer, diabetes and neurological diseases and was Director of the Institute for 15 years. In addition, he is an advocate for increasing public support for science and medical research and is known for his science communication and public science outreach.
Dr. Woodgett succeeds TFRI’s founding president Dr. Victor Ling, O.C., O.B.C., PhD who has led the Institute since its creation in 2007. For more, see https://www.tfri.ca/updates/news/news-item/distinguished-toronto-scientist-dr-jim-woodgett-takes-up-leadership-of-terry-fox-research-institute-on-august-1.
Fall 2025 Early Career Researcher Workshop – Applications Now Open
The CIHR Institute of Cancer Research is pleased to announce the open call for applications for its 2025 Early Career Researcher (ECR) Workshop, in partnership with the Canadian Cancer Research Alliance, Canadian Cancer Society, Cancer Research Society, Ontario Institute f... Read More »
The CIHR Institute of Cancer Research is pleased to announce the open call for applications for its 2025 Early Career Researcher (ECR) Workshop, in partnership with the Canadian Cancer Research Alliance, Canadian Cancer Society, Cancer Research Society, Ontario Institute f... Read More »
Investment in Cancer Research in 2022
Today, the CCRA released its latest report on the investment in cancer research from 2005 to 2022, with a focus on the period 2020-2022 to examine the potential impact of COVID-19. There was $526M invested in cancer research in 2022. The overall cancer research inve... Read More »
Today, the CCRA released its latest report on the investment in cancer research from 2005 to 2022, with a focus on the period 2020-2022 to examine the potential impact of COVID-19. There was $526M invested in cancer research in 2022. The overall cancer research inve... Read More »